Key Market Indicators
Greek beta-blocking medicine sales are set to reach around $72 million by 2026. In 2021, the market was valued at $79.2 million, dropping by 1% year on year. This decrease follows a 3.7% year on year rise since 2003. In the 2021 rankings, Greece came in at 8th place, behind Belgium, which had sales of $79.2 million. Italy, Canada and Australia took 2nd, 3rd and 4th places respectively.
